Literature DB >> 33729073

B cells and upper airway disease: allergic rhinitis and chronic rhinosinusitis with nasal polyps evaluated.

Harsha H Kariyawasam1,2,3, Louisa K James4.   

Abstract

Introduction: The first mucosal site to encounter inhaled allergen, antigen, and microbes is the upper airway. It must perforce have a rapid system of environmental threat recognition and self-defense. B cells play a critical role in such airway host-defense, tissue surveillance, and immune modulation. Several common upper airway diseases can be defined in the expression of either exaggerated or dysregulated B-cell function within T2-high mucosal inflammatory states.Areas covered: In this review, the authors discuss the immunology of allergic rhinitis (AR) and chronic rhinosinusitis with nasal polyps (CRSwNP) in the context of highlighting key aspects of B-cell biology and function. The review is based on the findings of a literature search using the terms B cells, rhinitis, nasal polyps, and rhinosinusitis.Expert opinion: Despite the emerging role of B-cell overdrive and dysfunction in upper airway disease, studies are lacking specifics to B cells, particularly in association with sinonasal infection and mucosal inflammation. There is a pressing need to focus on how respiratory inflammation, alongside impaired or exaggerated B-cell function, amplifies and further dysregulates immune signaling pathways in the disease setting of AR and CRSwNP.

Entities:  

Keywords:  B cells; allergic rhinitis; nasal polyps; rhinosinusitis

Mesh:

Year:  2021        PMID: 33729073     DOI: 10.1080/1744666X.2021.1905527

Source DB:  PubMed          Journal:  Expert Rev Clin Immunol        ISSN: 1744-666X            Impact factor:   4.473


  1 in total

1.  Increased B Cell-Activating Factor Expression Is Associated with Postoperative Recurrence of Chronic Rhinosinusitis with Nasal Polyps.

Authors:  Fang Zhang; Zhenhang Xu; Xi He; Yi Sun; Chong Zhao; Jianhui Zhang
Journal:  Mediators Inflamm       Date:  2022-04-08       Impact factor: 4.529

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.